Cargando…
Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection
BACKGROUND: Onchocerciasis (“river blindness”), is a neglected tropical disease caused by the filarial nematode Onchocerca volvulus and transmitted to humans through repeated bites by infective blackflies of the genus Simulium. Moxidectin was approved by the United States Food and Drug Administratio...
Autores principales: | Tan, Beesan, Opoku, Nicholas, Attah, Simon K., Awadzi, Kwablah, Kuesel, Annette C., Lazdins-Helds, Janis, Rayner, Craig, Ryg-Cornejo, Victoria, Sullivan, Mark, Fleckenstein, Lawrence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986118/ https://www.ncbi.nlm.nih.gov/pubmed/35333880 http://dx.doi.org/10.1371/journal.pntd.0010005 |
Ejemplares similares
-
A Randomized, Single-Ascending-Dose, Ivermectin-Controlled, Double-Blind Study of Moxidectin in Onchocerca volvulus Infection
por: Awadzi, Kwablah, et al.
Publicado: (2014) -
Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch
por: Awadzi, K., et al.
Publicado: (2015) -
Phenotypic Evidence of Emerging Ivermectin Resistance in Onchocerca volvulus
por: Osei-Atweneboana, Mike Y., et al.
Publicado: (2011) -
The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data
por: Turner, Hugo C, et al.
Publicado: (2015) -
Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial
por: Opoku, Nicholas O, et al.
Publicado: (2018)